Eosinophilic esophagitis an update in children
Keywords:
Allergy, biomarkers, children, eosinophilic esophagitis, pediatricsAbstract
Eosinophilic esophagitis (EoE) is an emerging antigen-mediated, inflammatory disease of unknown etiology. EoE affects about 1/2,000 patients in the United States (US), with a higher prevalence rate in adults (43.4/100,000) than in children (29.5/100,000), prevailing in Caucasians and male sex. EoE is a multifactorial disease typically characterized by type 2 inflammation. Pathogenesis is not entirely understood and is likely non-IgE mediated. Food allergens trigger EoE, stimulating the dysregulated immune cells through an impaired esophageal epithelial barrier. Clinical presentation of EoE depends on age and mainly includes food refusal, vomiting, abdominal or chest pain, dysphagia, and food impaction. Endoscopy is the gold standard to diagnose EoE. The goal of EoE therapy is to achieve clinical and histological remission to prevent esophageal fibrosis and improve patients' quality of life (QoL). Cornerstones of therapy are PPIs, topical steroids, and elimination diets. Over recent decades, research progress has been made in terms of a greater understanding of the EoE pathogenesis and new therapeutic approaches. However, there are still several unmet needs, such as non-invasive tools and biomarkers for monitoring the disease.
References
Votto M, De Filippo M, Lenti MV, et al. Diet Therapy in Eosinophilic Esophagitis. Focus on a Personalized Approach. Front Pediatr. 2022;9:1-12.
Licari A, Votto M, D’Auria E, et al. Eosinophilic Gastrointestinal Diseases in Children: A Practical Review. Curr Pediatr Rev. 2019;16(2):106-14.
Votto M, Raffaele A, De Filippo M, et al. Eosinophilic gastrointestinal disorders in children and adolescents: A single-center experience. Dig Liver Dis. 2022;54(2):214-20.
Wechsler JB, Hirano I. Biological Therapies for Eosinophilic Gastrointestinal Diseases. J Allergy Clin Immunol. 2018;142(1):24.
Votto M, Marseglia GL, De Filippo M, et al. Early Life Risk Factors in Pediatric EE: Could We Prevent This Modern Disease? Front Pediatr. 2020;8:1-10.
Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic Esophagitis in Children and Adults: A Systematic Review and Consensus Recommendations for Diagnosis and Treatment. Sponsored by the American Gastroenterological Association (AGA) Institute and North American Society of Pediatric Gastroenterol. Gastroenterology. 2007;133(4):1342-63.
Votto M, Castagnoli R, de Filippo M, et al. Behavioral issues and quality of life in children with eosinophilic esophagitis. Minerva Pediatr. 2020;72(5):424-32.
Shaheen NJ, Mukkada V, Eichinger CS, et al. Natural history of eosinophilic esophagitis: a systematic review of epidemiology and disease course. Dis Esophagus. 2018;31(8):1-14.
Arias A, Pérez-Martínez I, Tenías JM, et al. Systematic review with meta-analysis: The incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther. 2016;43(1):3-15.
Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299(6710):1259-60.
Liu AH. Revisiting the hygiene hypothesis for allergy and asthma. J Allergy Clin Immunol. 2015;136(4):860-5.
Bach J-F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347(12):911-20.
Silva FMCE, Oliveira EE, Ambrósio MGE, et al. High-fat diet-induced obesity worsens TH2 immune response and immunopathologic characteristics in murine model of eosinophilic oesophagitis. Clin Exp Allergy. 2020;50(2):244-55.
Votto M, De Filippo M, Olivero F, et al. Malnutrition in eosinophilic gastrointestinal disorders. Nutrients. 2021;13(1):1-12.
Dellon ES. The Esophageal Microbiome in Eosinophilic Esophagitis. Gastroenterology. 2016;151(2):364-365.
Jensen ET, Kappelman MD, Kim HP, et al. Early life exposures as risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2013;57(1):67-71.
Votto M, De Filippo M, Caminiti L, et al. Eosinophilic gastrointestinal disorders and allergen immunotherapy: Lights and shadows. Pediatr Allergy Immunol. 2021;32(5):814-23.
Alexander ES, Martin LJ, Collins MH, et al. Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol. 2014;134(5):1084.
Arora M, Bagi P, Strongin A, et al. Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome. J Clin Immunol. 2017;37(7):695-700.
Paluel-Marmont C, Bellon N, Barbet P, et al. Eosinophilic esophagitis and colonic mucosal eosinophilia in Netherton syndrome. J Allergy Clin Immunol. 2017;139(6):2003-5.
Henderson CJ, Ngeow J, Collins MH, et al. Increased prevalence of eosinophilic gastrointestinal disorders in pediatric PTEN hamartoma tumor syndromes. J Pediatr Gastroenterol Nutr. 2014;58(5):553-60.
Sherrill JD, Kc K, Wang X, et al. Whole-exome sequencing uncovers oxidoreductases DHTKD1 and OGDHL as linkers between mitochondrial dysfunction and eosinophilic esophagitis. JCI insight. 2018;3(8).
Votto M, Bonitatibus G, De Filippo M, et al. Nutritional status in eosinophilic gastrointestinal disorders: A pediatric case‐control study. Pediatr Allergy Immunol. 2022;33(S27):47-51.
Rossetti D, Isoldi S, Oliva S. Eosinophilic Esophagitis: Update on Diagnosis and Treatment in Pediatric Patients. Pediatr Drugs. 2020;22(4):343-56.
Furuta GT, Katzka DA. Eosinophilic Esophagitis. Ingelfinger JR, ed. N Engl J Med. 2015;373(17):1640.
Chen JW, Kao JY. Eosinophilic esophagitis: update on management and controversies. BMJ. 2017;359.
Barni S, Arasi S, Mastrorilli C, et al. Pediatric eosinophilic esophagitis: a review for the clinician. Ital J Pediatr. 2021;47(1):1-14.
Sugnanam KKN, Collins JT, Smith PK, et al. Dichotomy of food and inhalant allergen sensitization in eosinophilic esophagitis. Allergy. 2007;62(11):1257-60.
Spergel JM, Brown-Whitehorn TF, Beausoleil JL, et al. 14 years of eosinophilic esophagitis: Clinical features and prognosis. J Pediatr Gastroenterol Nutr. 2009;48(1):30-6.
Hill DA, Dudley JW, Spergel JM. The prevalence of eosinophilic esophagitis in pediatric patients with IgE-mediated food allergy. J allergy Clin Immunol Pract. 2017;5(2):369.
Talathi S, Knight T, Dimmitt R, et al. Concurrent eosinophilic esophagitis in pediatric patients with inflammatory bowel disease: A case series. Ann Allergy, Asthma Immunol. 2019;123(3):313-6.
Abonia JP, Wen T, Stucke EM, et al. High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders. J Allergy Clin Immunol. 2013;132(2):378-86.
Capucilli P, Cianferoni A, Grundmeier RW, et al. Comparison of comorbid diagnoses in children with and without eosinophilic esophagitis in a large population. Ann Allergy Asthma Immunol. 2018;121(6):711-6.
Peterson K, Firszt R, Fang J, et al. Risk of Autoimmunity in EE and Families: A Population-Based Cohort Study. Am J Gastroenterol. 2016;111(7):926-32.
Kottyan L, Spergel JM, Cianferoni A. Immunology of the ancestral differences in eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2019;122(5):443-4.
Biedermann L, Holbreich M, Atkins D, et al. Food-induced immediate response of the esophagus—A newly identified syndrome in patients with eosinophilic esophagitis. Allergy Eur J Allergy Clin Immunol. 2021;76(1):339-47.
Holbreich M, Straumann A. Features of food‐induced immediate response in the esophagus (FIRE) in a series of adult patients with eosinophilic esophagitis. Allergy. 2021;76(9):2893-5.
Votto M, Naso M, De Filippo M, et al. Food‐induced immediate response of the esophagus: A first report in the pediatric age. Allergy. 2022;77(2):711-2.
Rassbach W, Rubenstein JH, Elkins M, et al. Age-Based Differences in the Diagnosis and Management of Esophageal Eosinophilia. J allergy Clin Immunol Pract. 2015;3(1):81.
Assa’ad AH, Putnam PE, Collins MH, et al. Pediatric patients with eosinophilic esophagitis: An 8-year follow-up. J Allergy Clin Immunol. 2007;119(3):731-8.
Savarino E, Tolone S, Caccaro R, et al. Clinical, endoscopic, histological and radiological characteristics of Italian patients with eosinophilic oesophagitis. Dig Liver Dis. 2015;47(12):1033-8.
Dellon ES, Speck O, Woodward K, et al. Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy. Mod Pathol. 2015;28(3):383.
Hirano I, Moy N, Heckman MG, et al. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62(4):489-95.
Kasagi Y, Dods K, Wang JX, et al. Fibrostenotic eosinophilic esophagitis may reflect epithelial lysyl oxidase induction by fibroblasts-derived tumor necrosis factor-α. J Allergy Clin Immunol. 2019;144(1):171.
Whelan KA, Godwin BC, Wilkins B, et al. Persistent Basal Cell Hyperplasia is Associated with Clinical and Endoscopic Findings in Patients With Histologically Inactive Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2020;18(7):1475.
Muir AB, Brown-Whitehorn T, Godwin B, et al. Eosinophilic esophagitis: early diagnosis is the key. Clin Exp Gastroenterol. 2019;12:391.
Lucendo AJ, Arias Á, González-Cervera J, et al. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: A prospective study on the food cause of the disease. J Allergy Clin Immunol. 2013;131(3):797-804.
Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018;155(4):1022-33.
Constantine G, Seth N, Chokshi N, et al. Combination Steroid and Test-based Food Elimination for Eosinophilic Esophagitis: A Retrospective Analysis. J Pediatr Gastroenterol Nutr. 2017;64(6):933.
Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: Updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128(1):3-20
Lucendo AJ, Molina-Infante J, Arias Á, et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United Eur Gastroenterol J. 2017;5(3):335.
De Bruyne P, Ito S. Toxicity of long-term use of proton pump inhibitors in children. Arch Dis Child. 2018;103(1):78-82.
Eusebi LH, Rabitti S, Artesiani ML, et al. Proton pump inhibitors: Risks of long-term use. J Gastroenterol Hepatol. 2017;32(7):1295-1302.
Chehade M, Aceves SS. Treatment of Eosinophilic Esophagitis: Diet or Medication? J allergy Clin Immunol Pract. 2021;9(9):3249-56.
Steinbach EC, Hernandez M, Dellon ES. Eosinophilic Esophagitis and the Eosinophilic Gastrointestinal Diseases: Approach to diagnosis and management. J allergy Clin Immunol Pract. 2018;6(5):1483.
Licari A, Manti S, Marseglia A, et al. Food allergies: Current and future treatments. Med. 2019;55(5):1-13.
Peterson KA, Byrne KR, Vinson LA, et al. Elemental diet induces histologic response in adult eosinophilic esophagitis. Am J Gastroenterol. 2013;108(5):759-66.
Markowitz JE, Spergel JM, Ruchelli E, et al. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol. 2003;98(4):777-82.
Cianferoni A, Shuker M, Brown-Whitehorn T, et al. Food avoidance strategies in eosinophilic oesophagitis. Clin Exp Allergy. 2019;49(3):269-84.
Akhondi H. Diagnostic approaches and treatment of eosinophilic esophagitis. A review article. Ann Med Surg. 2017;20:69.
Clayton F, Fang JC, Gleich GJ, et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology. 2014;147(3):602-9.
Assa’ad AH, Gupta SK, Collins MH, et al. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology. 2011;141(5):1593-1604.
Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut. 2010;59(1):21-30.
Markowitz JE, Jobe L, Miller M, et al. Safety and Efficacy of Reslizumab for Children and Adolescents With Eosinophilic Esophagitis Treated for 9 Years. J Pediatr Gastroenterol Nutr. 2018;66(6):893-97.
Spergel JM, Rothenberg ME, Collins MH, et al. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2012;129(2).
Lieberman JA, Zhang J, Whitworth J, et al. A randomized, double-blinded, placebo-controlled study of the use of viscous oral cromolyn sodium for the treatment of eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2018;120(5):527-31.
Licari A, Castagnoli R, Marseglia A, et al. Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents. Pediatr Drugs. 2020;22(3):295-310.
Votto M, De Filippo M, Castagnoli R, et al. Non-invasive biomarkers of eosinophilic esophagitis. Acta Biomed. 2021;92(3).
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Martina Votto, Matteo Naso, Andrea Martina Clemente, Maria De Filippo, Ginevra Gargiulo, Veronica Granone, Giulia Siri, Gian Luigi Marseglia, Amelia Licari
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
